gilead sciences ireland uc - bictegravir, emtricitabine, tenofovir alafenamide, fumarat - hiv-infektioner - antivirala medel för systemisk användning - biktarvy is indicated for the treatment of human immunodeficiency virus 1 (hiv 1) infection in adults and paediatric patients at least 2 years of age and weighing at least 14 kg i without present or past evidence of viral resistance to the integrase inhibitor class, emtricitabine or tenofovir. (se avsnitt 5.
Europeiska unionen -
svenska -
EMA (European Medicines Agency)